Article

Adrenaline but not noradrenaline is a determinant of exercise-induced lipid mobilization in human subcutaneous adipose tissue

Institut National de la Santé et de la Recherche Médicale, Toulouse, France.
The Journal of Physiology (Impact Factor: 5.04). 06/2009; 587(Pt 13):3393-404. DOI: 10.1113/jphysiol.2009.168906
Source: PubMed

ABSTRACT

The relative contribution of noradrenaline (norepinephrine) and adrenaline (epinephrine) in the control of lipid mobilization in subcutaneous adipose tissue (SCAT) during exercise was evaluated in men treated with a somatostatin analogue, octreotide. Eight lean and eight obese young men matched for age and physical fitness performed 60 min exercise bouts at 50% of their maximal oxygen consumption on two occasions: (1) during i.v. infusion of octreotide, and (2) during placebo infusion. Lipolysis and local blood flow changes in SCAT were evaluated using in situ microdialysis. Infusion of octreotide suppressed plasma insulin and growth hormone levels at rest and during exercise. It blocked the exercise-induced increase in plasma adrenaline while that of noradrenaline was unchanged. Plasma natriuretic peptides (NPs) level was higher at rest and during exercise under octreotide infusion in lean men. Under placebo, no difference was found in the exercise-induced increase in glycerol between the probe perfused with Ringer solution alone and that with phentolamine (an alpha-adrenergic receptor antagonist) in lean subjects while a greater increase in glycerol was observed in the obese subjects. Under placebo, propranolol infusion in the probe containing phentolamine reduced by about 45% exercise-induced glycerol release; this effect was fully suppressed under octreotide infusion while noradrenaline was still elevated and exercise-induced lipid mobilization maintained in both lean and obese individuals. In conclusion, blockade of beta-adrenergic receptors during exercise performed during infusion of octreotide (blocking the exercise-induced rise in adrenaline but not that of noradrenaline) does not alter the exercise-induced lipolysis. This suggests that adrenaline is the main adrenergic agent contributing to exercise-induced lipolysis in SCAT. Moreover, it is the combined action of insulin suppression and NPs release which explains the lipolytic response which remains under octreotide after full local blockade of fat cell adrenergic receptors. For the moment, it is unknown if results apply specifically to SCAT and exercise only or if conclusions could be extended to all forms of lipolysis in humans.

Download full-text

Full-text

Available from: Jens Bülow, Mar 23, 2015
    • "c o m / e u j i m the lipolysis in a localized abdominal adipose tissue. The lipolysis effect by microcurrent is explained by an increase of adenosine triphosphate—ATP production, amino acid transport, and protein synthesis [16] [17] [18] which promotes an increase of catecholamines' concentration, and consequently the activation of triglyceride lipase and hormone-sensitive lipase enzymes [19]. In addition, a thermal effect increases the blood flow and metabolism changes in membrane polarity, causing an increase of organelles' numbers responsible for cellular activities [16]. "

    No preview · Conference Paper · Nov 2015
  • Source
    • "In contrast, α-2-adrenergic receptors are Gi-protein coupled, inhibiting adenylate cyclase activation and thus preventing the formation of cAMP. Noradrenaline has a greater affinity for the α-2-adrenergic receptor than for the β-adrenergic receptors, suggesting a role for the α-adrenergic pathway in the regulation of lipolysis in human subcutaneous AT under conditions of exercise or stress (24). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Numerous studies address the physiology of adipose tissue (AT). The interest surrounding the physiology of AT is primarily the result of the epidemic outburst of obesity in various contemporary societies. Briefly, the two primary metabolic activities of white AT include lipogenesis and lipolysis. Throughout the last two decades, a new model of AT physiology has emerged. Although AT was considered to be primarily an abundant energy source, it is currently considered to be a prolific producer of biologically active substances, and, consequently, is now recognized as an endocrine organ. In addition to leptin, other biologically active substances secreted by AT, generally classified as cytokines, include adiponectin, interleukin-6, tumor necrosis factor-alpha, resistin, vaspin, visfatin, and many others now collectively referred to as adipokines. The secretion of such biologically active substances by AT indicates its importance as a metabolic regulator. Cell turnover of AT has also recently been investigated in terms of its biological role in adipogenesis. Consequently, the objective of this review is to provide a comprehensive critical review of the current literature concerning the metabolic (lipolysis, lipogenesis) and endocrine actions of AT.
    Full-text · Article · Mar 2014 · Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas / Sociedade Brasileira de Biofisica ... [et al.]
  • Source
    • "Epinephrine Increases glucose oxidation in muscle. Increases lipolysis (beta effect) [125] Norepinephrine Increases lipid oxidation in muscle [126] GH Stimulation of lipolysis and ketogenesis[127]; in the muscle and liver, GH stimulates triglyceride (TG) uptake, by enhancing lipoprotein lipase (LPL) expression, and its subsequent storage [128]; increases whole body lipid oxidation and non oxidative glucose utilization and decreases glucose oxidation [129]; increases Lipox max [34] IGF-I Mediates many of the anabolic actions of growth hormone. It stimulates muscle protein synthesis, promotes glycogen storage and enhances lipolysis [130] Interleukin-6 (IL-6) Adipokine and myokine acting as an energy sensor and activating AMP-activated kinase and enhancing glucose disposal, lipolysis and fat oxidation [131] Cortisol Increases adipogenesis and lipolysis; decreases non-insulin mediated glucose uptake B-endorphin Lipolysis blunted by naloxone [132] [133] Adiponectin Increases muscular lipid oxidation via phosphorylation of AMPK [134] Leptin Increases muscle fat oxidation and decreases muscle fat uptake, thereby decreasing intramyocellular lipid stores [134] J.-F. "
    [Show abstract] [Hide abstract]
    ABSTRACT: On peut déterminer une intensité d’exercice pour laquelle l’oxydation des lipides est maximale, dénommée Lipoxmax, Fatoxmax ou Fatmax. La mesure du Lipoxmax par calorimétrie d’effort est reproductible, mais ce paramètre est modifié par plusieurs des situations physiologiques (entraînement physique, exercice ou repas réalisé dans les heures précédentes). Sa mesure prédit le débit d’oxydation lipidique à plateau d’un exercice modéré à puissance constante de 45 à 60 minutes réalisé à l’intensité correspondante. Il pourrait être un marqueur de « bonne forme métabolique » et reflète la respiration mitochondriale. Le Lipoxmax est influencé par les catécholamines, l’hormone de croissance et l’IGF-I. Ses variations sont liées aux modifications du niveau de la citrate synthase musculaire et à la capacité des mitochondries à oxyder les acides gras. Une méta-analyse montre qu’un entraînement à ce niveau est efficace pour réduire la masse grasse, épargner la masse maigre, augmenter la capacité à oxyder les lipides pendant l’exercice, réduire la glycémie et l’HbA1c dans le diabète de type 2, et diminuer le cholestérol circulant.
    Full-text · Article · Apr 2011 · Science & Sports
Show more